(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics >  Tumor Markers
 
 Tumor Markers Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  3  4  5  6  7  8  9  10  11  12  Next »
2015 Analysis of Emerging Tumor Markers, and Strategic Profiles of Leading Suppliers

This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.



 

$3500.00
       
2015 Global Tumor Markers Testing Market Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$3500.00
       
2016 Emerging Strategies for the Global Tumor Marker Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$3500.00
       
Tumor Markers: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$3500.00
       
Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products

The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.

Contains 260 pages and 30 tables

 

$2850.00
       
Emerging Tumor Markers and Companies Developing Innovative Technologies and Products

Highlights

  • Comprehensive 260-page market and technological assessment.
  • Medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as :

  • - Biochemical Markers
    - Oncogenes
    - Growth Factors
    - Hormones
    - Colony Stimulating Factors
    - Lymphokines
    - Immunohistochemical Stains.



 

$2850.00
       
Emerging Tumor Markers: New Assays and Companies Developing Innovative Technologies and Products

Highlights

  • Comprehensive 260-page market and technological assessment.
  • Medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as :

  • - Biochemical Markers
    - Oncogenes
    - Growth Factors
    - Hormones
    - Colony Stimulating Factors
    - Lymphokines
    - Immunohistochemical Stains....

 

$2850.00
       
Leading Cancer Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 80 pages

 

$2500.00
       
Leading Tumor Marker Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants

This 80-page report presents strategic analyses of major current and emerging suppliers of tumor markers.

For each company the report presents:

  • Sales
  • Market shares
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
Competitive Intelligence: Leading Tumor Marker Diagnostics Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
CompetitiveWatch Tumor Markers: Strategic Assessments of Major Suppliers

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.

The assessments include:

  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
2014 Tumor Markers Testing Market: Strategic Assessments
of Major Suppliers


This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. 

The assessments include:

  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
2014 Analysis of Leading Tumor Marker Diagnostic Testing Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
2014 Analysis of Leading Tumor Marker Testing Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
2015 CompetitiveWatch Tumor Markers: Strategic Assessments of Major Suppliers

This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents....

 

$2500.00
       
2015 CompetitiveWatch Tumor Markers: Major Suppliers Strategic Assessments

This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents....

 

$2500.00
       
2015 Tumor Marker Testing Market: Strategic Assessments of Current and Emerging Competitors

This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents....

 

$2500.00
       
2016 Emerging Opportunities in the Tumor Markers Testing Market: Strategic Assessments of Major Suppliers

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.

The assessments include:

  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
« Previous     3  4  5  6  7  8  9  10  11  12   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X